Skip to main content
SpringerLink
Log in

US FDA requests hold on early clinical trials of atezolizumab

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see Reactions 1668 p6; 803269733

Reference

  • Roche. TECENTRIQ GO29695 (NCT02431208) and BO29562 (NCT02631577) partial clinical hold reactive statement. Media Release : 15 Sep 2017. Available from: URL: http://www.roche.coms

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

US FDA requests hold on early clinical trials of atezolizumab. Reactions Weekly 1671, 6 (2017). https://doi.org/10.1007/s40278-017-36440-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-36440-8

Search

Navigation